Find Paid Clinical Trials in ----- , New Mexico

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in New Mexico

Top of Directory » All Locations » United States » New Mexico




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Study Evaluating the Efficacy and Safety of SBI-087 in Seropositive Subjects With Active Rheumatoid Arthritis

    Condition:   Active Rheumatoid Arthritis
    Intervention:   Drug: SBI-087
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

    Condition:   Chronic Myelogenous Leukemia
    Intervention:   Drug: Gleevec (imatinib), valproic acid
    Sponsor:   New Mexico Cancer Care Alliance
    Recruiting - verified November 2009

  • Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma

    Condition:   Squamous Cell Carcinoma
    Intervention:   Drug: Tarceva, Torisel
    Sponsors:   University of New Mexico;   Genentech
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

    Condition:   Melanoma
    Intervention:   Drug: paclitaxel, carboplatin, temozolomide
    Sponsor:   New Mexico Cancer Care Alliance
    Recruiting - verified November 2009

  • Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer

    Condition:   Non-small Cell Lung Cancer
    Intervention:   Drug: Gleevec, paclitaxel
    Sponsors:   New Mexico Cancer Care Alliance;   Fred Hutchinson Cancer Research Center;   Novartis
    Recruiting - verified November 2009

  • Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

    Condition:   Gout
    Interventions:   Drug: placebo;   Drug: BCX4208
    Sponsor:   BioCryst Pharmaceuticals
    Recruiting - verified November 2009

  • Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis - The ADAMO Trial

    Conditions:   Low Bone Mass;   Low Bone Mineral Density;   Males With Osteoporosis;   Osteopenia;   Osteoporosis
    Interventions:   Drug: 60 mg denosumab;   Other: Placebo
    Sponsor:   Amgen
    Recruiting - verified November 2009

  • Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

    Condition:   Castration-Resistant Prostate Cancer
    Interventions:   Drug: MDV3100;   Drug: Placebo
    Sponsor:   Medivation, Inc.
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain

    Conditions:   Low Back Pain;   Low Back Pain, Recurrent
    Interventions:   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Sciatic Pain

    Condition:   Sciatica
    Interventions:   Drug: REGN475;   Drug: REGN475;   Drug: Placebo Injection
    Sponsors:   Regeneron Pharmaceuticals;   Sanofi-Aventis
    Recruiting - verified November 2009

  • A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

    Conditions:   Osteoarthritis;   Osteoarthritis, Hip;   Osteoarthritis, Knee;   Pain;   Arthralgia;   Joint Pain
    Interventions:   Drug: JNJ-42160443;   Drug: Placebo;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Study of Blood Samples From Newborns With Down Syndrome

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects With Confirmed or Suspected Influenza Infection

    Conditions:   Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Feverishness;   Fatigue
    Interventions:   Drug: Peramivir;   Drug: Peramivir
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

    Condition:   Myelofibrosis
    Interventions:   Drug: INCB018424;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009

  • Study of Patients With Advanced Non-Small Cell Lung Cancer

    Condition:   Advanced Non-Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel;   Biological: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Comparison of Standard of Care or Treatment on Protocol

    Conditions:   Gastrointestinal Diseases;   Genitourinary Diseases;   Skin Cancers
    Intervention:   Other: standard of care
    Sponsor:   New Mexico Cancer Care Alliance
    Recruiting - verified November 2009

  • Study of Erlotinib, Cisplatin, Radiotherapy vs Cisplatin and Radiotherapy in Carcinoma of Head and Neck

    Condition:   Squamous Cell Carcinoma of the Head and Neck
    Interventions:   Drug: cisplatin + XRT+erlotinib;   Drug: Cisplatin + XRT
    Sponsors:   New Mexico Cancer Care Alliance;   University of Washington;   Genentech
    Recruiting - verified November 2009

  • Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma

    Conditions:   Advanced Solid Tumors;   Lymphomas
    Intervention:   Drug: 20(S)Camptothecin Propionate (CZ48)
    Sponsor:   New Mexico Cancer Care Alliance
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Dutogliptin;   Drug: Placebo
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified October 2009

  • Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

    Condition:   Benign Prostatic Hyperplasia (BPH)
    Interventions:   Drug: NX-1207;   Drug: Placebo
    Sponsor:   Nymox Corporation
    Recruiting - verified October 2009

  • A Study of LY2189102 in Patients With Type 2 Diabetes

    Condition:   Type 2 Diabetes
    Interventions:   Drug: LY2189102;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

    Condition:   Asthma
    Interventions:   Drug: QMF149 Twisthaler®;   Drug: Mometasone Twisthaler®
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009

  • AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

    Conditions:   Neuropathic Pain;   Mechanical Hypersensitivity
    Interventions:   Drug: AZD2066;   Drug: Placebo
    Sponsors:   AstraZeneca;   Quintiles
    Recruiting - verified November 2009

  • An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Intervention:   Drug: Dimebon
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: gemcitabine/carboplatin;   Drug: gemcitabine/carboplatin plus BSI-201
    Sponsor:   BiPar Sciences
    Recruiting - verified November 2009

  • Abatacept Versus Adalimumab Head-to-Head

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Abatacept;   Drug: Adalimumab
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

    Condition:   Osteoporosis, Post-Menopausal
    Interventions:   Drug: Teriparatide;   Drug: Zoledronic Acid
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Long Term Safety Study of Tanezumab in Chronic Low Back Pain

    Condition:   Low Back Pain
    Interventions:   Biological: Tanezumab 20 mg;   Biological: Tanezumab 10 mg
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance

    Conditions:   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Samples From Patients With Lung Cancer

    Condition:   Lung Cancer
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

    Conditions:   Chordoma;   Desmoid Tumor;   Sarcoma
    Interventions:   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Effect of LY2062430 on the Progression of Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: LY2062430;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

    Condition:   Neuroblastoma
    Interventions:   Genetic: loss of heterozygosity analysis;   Other: cytology specimen collection procedure;   Procedure: biopsy
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster

    Conditions:   Herpes Zoster;   Shingles
    Interventions:   Drug: valacyclovir;   Drug: FV-100;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
    Sponsor:   Inhibitex
    Recruiting - verified November 2009

  • Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

    Condition:   Sarcoma
    Interventions:   Other: biologic sample preservation procedure;   Other: medical chart review
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

    Conditions:   Leukemia;   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

    Condition:   Sarcoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting Tumor Samples From Patients With Gynecological Tumors

    Condition:   Cancer
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma

    Condition:   Lymphoma
    Interventions:   Other: biologic sample preservation procedure;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Kidney Tumors in Young Patients

    Conditions:   Kidney Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Genetic: loss of heterozygosity analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Phase 2 Study of AMG 785 in Postmenopausal Women With Low Bone Mineral Density

    Conditions:   Low Bone Mineral Density;   Postmenopausal Osteoporosis
    Interventions:   Drug: AMG 785;   Drug: Active Comparator Alendronate;   Drug: Placebo;   Drug: AMG 785;   Drug: AMG 785;   Drug: AMG 785;   Drug: Placebo;   Drug: Active comparator teriparatide;   Drug: AMG 785
    Sponsor:   Amgen
    Recruiting - verified November 2009

  • A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: Nonbiologic DMARDs of investigator's choice
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

    Condition:   Breast Cancer
    Interventions:   Drug: bevacizumab;   Drug: docetaxel;   Drug: doxorubicin;   Drug: cyclophosphamide;   Drug: cyclophosphamide;   Drug: pegfilgrastim
    Sponsors:   National Surgical Adjuvant Breast and Bowel Project (NSABP);   Genentech;   US Oncology Research
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials